Baird Medical Investment Holdings Ltd BDMD

Morningstar Rating

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BDMD is trading at a LOCK|zWsD&# premium.
Price
$0.10
Fair Value
LOCK|?wX%Nt@
Uncertainty
LOCK|LQ jw^P
1-Star Price
LOCK|ZcS&R^W
5-Star Price
LOCK|R<P<>$w
Economic Moat
LOCK|&l
Capital Allocation
—

News

Trading Information

Previous Close Price
—
Day Range
—–—
52-Week Range
—–—
Bid/Ask
— / —
Shares Outstanding
56.52M
Market Cap
—
Volume/Avg
— / —

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
0.11
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Baird Medical Investment Holdings Ltd is a specialized healthcare innovator dedicated exclusively to thyroid-related diseases and a microwave ablation (MWA) medical device manufacturer and provider in China. The company combines clinical expertise with technologies to develop non-invasive treatment solutions. Its proprietary MWA medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Its core activities include the development and commercialization of thyroid microwave ablation systems and an active R&D pipeline of AI-integrated robotic systems, integrating hardware, software, and system-based solutions.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
146
Website
—

Valuation

Metric
BDMD
Price/Earnings (Normalized)
—
Price/Book Value
0.08
Price/Sales
0.11
Price/Cash Flow
0.65
Price/Earnings
BDMD

Financial Strength

Metric
BDMD
Quick Ratio
0.88
Current Ratio
1.29
Interest Coverage
−20.05
Quick Ratio
BDMD

Profitability

Metric
BDMD
Return on Assets (Normalized)
−21.99%
Return on Equity (Normalized)
−47.68%
Return on Invested Capital (Normalized)
−28.62%
Return on Assets
BDMD

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|#z?s?zLOCK|Ck$r@$178B
Medtronic PLC
MDT
LOCK|#D<n%sLOCK|CD^!>$128B
Stryker Corp
SYK
LOCK|?$YGjL^yLOCK|TV^$118B
Boston Scientific Corp
BSX
LOCK|!&M?rqLOCK|k>>l>$61B
Edwards Lifesciences Corp
EW
LOCK|@RVg%$S?LOCK|g$s%$59B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|>Bbmm@DLOCK|BB$36B
DexCom Inc
DXCM
LOCK|QfFt@M#LOCK|WX<$$30B
Koninklijke Philips NV ADR
PHG
LOCK|k^LOCK|CyS$28B
Steris PLC
STE
LOCK|xD>qs^dLOCK|!$y%$25B
Zimmer Biomet Holdings Inc
ZBH
LOCK|LHX>@Kx$LOCK|r?<$19B

Sponsor Center